ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

ZIOPTAN
Glaucoma
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

ZIOPTAN Rx

Generic Name and Formulations:
Tafluprost 0.0015%; oph soln; preservative-free.

Company:
Akorn, Inc.

Therapeutic Use:

Indications for ZIOPTAN:

For reducing elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension.

Adult:

1 drop in conjunctival sac of affected eye(s) once daily in the PM.

Children:

Not recommended.

Warnings/Precautions:

Do not exceed recommended dose (may reduce efficacy). Active intraocular inflammation (eg, iritis/uveitis). Aphakia. Pseudophakia with torn posterior lens capsule. Risk of macular edema. Pregnancy (Cat.C); use effective contraception. Nursing mothers.

Interactions:

Allow at least 5 minutes between application of other topical oph agents.

Pharmacological Class:

Prostaglandin analogue.

Adverse Reactions:

Conjunctival hyperemia, ocular stinging/irritation, ocular pruritus including allergic conjunctivitis, cataract, dry eye, ocular pain, increased ocular pigmentation (eg, iris, eyelid, eyelashes; may be permanent), other eyelash changes, blurred vision, macular edema, headache, cold, cough, urinary tract infection.

How Supplied:

Single-use containers (0.3mL)—30, 90

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs